Web Results

Sunitinib - Wikipedia

en.wikipedia.org/wiki/Sunitinib

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell ...

RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...

www.sutent.com/

SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.

Sunitinib - Chemotherapy Drugs - Chemocare

chemocare.com/chemotherapy/drug-info/Sunitinib.aspx

Trade Name: Sutent <sup>®</sup> Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...

Definition of sunitinib malate - NCI Drug Dictionary - National ...

www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=299061

Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and ...

Sunitinib | C22H27FN4O2 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/Sunitinib

Sunitinib is an indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular ...

DrugBank: Sunitinib

www.drugbank.ca/drugs/DB01268

May 16, 2007 ... Sunitinib is metabolized primarily by the cytochrome P450 enzyme, CYP3A4, to produce its primary active metabolite, which is further ...

Sunitinib: Indications, Side Effects, Warnings - Drugs.com

www.drugs.com/cdi/sunitinib.html

Easy to read patient leaflet for sunitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sunitinib (Sutent®) | OncoLink

www.oncolink.org/cancer-treatment/chemotherapy/oncolink-rx/sunitinib-sutent-r

Jan 13, 2016 ... Sunitinib (Sutent®) is an oral multikinase inhibitor used in the treatment of some types of gastrointestinal stromal tumors, renal cell cancers and ...

Sunitinib (Sutent®) - Cancer information - Macmillan Cancer Support

www.macmillan.org.uk/cancerinformation/cancertreatment/treatmenttypes/biologicaltherapies/cancergrowthinhibitors/sunitinib.aspx

Find out more about sunitinib (also called Sutent®), which may be used to treat a type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal ...

Sutent (Sunitinib Malate): Side Effects, Interactions, Warning ... - RxList

www.rxlist.com/sutent-drug.htm

Mar 10, 2015 ... SUTENT, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib malate is described chemically as Butanedioic acid, hydroxy-, ...

More Info

Sunitinib: MedlinePlus Drug Information

medlineplus.gov

Aug 15, 2016 ... Sunitinib may cause serious or life-threatening damage to the liver. Tell your doctor if you have or have ever had liver disease or problems with ...

Sunitinib (Sutent) | Cancer Research UK

www.cancerresearchuk.org

May 12, 2015 ... Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.

Sunitinib Malate - National Cancer Institute

www.cancer.gov

Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research ...